SAN DIEGO, CA / ACCESSWIRE / August 12, 2021 / Dermata Therapeutics, Inc. (“Dermata” or the “Company”) (NASDAQ:DRMA)(NASDAQ:DRMAW), a clinical-stage medical dermatology company focused on identifying, developing and commercializing innovative pharmaceutical…
Dermata Therapeutics, Inc. Announces Pricing of Upsized $18.0 Million Initial Public Offering
Share this article
More News


(HTA.U) Technical Analysis and Trading Signals
November 19, 2026

Optimjack malware hits 178 websites
November 19, 2026


FBI ties $11.37 billion in crypto to cybercrime losses
November 19, 2026

(HYBR) Stock Market Analysis
November 19, 2026

Russia weighs letting investment funds hold crypto directly
November 19, 2026